Dural-Based Plasmacytoma Presenting as the Initial Sign of Multiple Myeloma: A Rare Skull Mass Every Radiologist Should Recognize

Dural-Based Plasmacytoma Presenting as the Initial Sign of Multiple Myeloma

A painless scalp lump may appear clinically insignificant. However, in rare circumstances, it may represent the first warning sign of an underlying systemic malignancy. In modern medical imaging practice, recognizing subtle radiologic clues can dramatically alter patient prognosis.

This article explores a rare but clinically critical entity: dural-based plasmacytoma presenting as the initial manifestation of multiple myeloma. We review the pathophysiology, epidemiology, radiology interpretation, CT imaging findings, MRI characteristics, differential diagnosis, diagnostic workflow, treatment strategies, and prognosis using a real-world clinical scenario.

For radiologists, emergency physicians, neurologists, oncologists, and medical imaging specialists, this case demonstrates how advanced radiology interpretation can identify systemic hematologic malignancy before catastrophic complications occur.

Clinical Scenario: An Apparently Benign Scalp Lump

A 42-year-old woman presented with a painless scalp mass that had initially been noticed by her hairstylist approximately four months earlier. The lesion gradually enlarged without neurologic symptoms.

Physical examination revealed:

A firm, non-tender subcutaneous nodule
Approximately 6 cm in diameter
Located over the right frontal skull
No focal neurologic deficits

Routine laboratory studies were initially unremarkable:

Complete blood count: normal
Comprehensive metabolic panel: normal
Urinalysis: normal

At first glance, the lesion appeared clinically indolent. However, medical imaging told a very different story.

Why This Case Matters in Modern Radiology

Dural-based plasmacytoma is exceptionally uncommon. Even more unusual is its presentation as the first manifestation of multiple myeloma.

In many patients, multiple myeloma is diagnosed after:

Diffuse bone pain
Anemia
Renal dysfunction
Hypercalcemia
Pathologic fractures

But in this case, the disease first appeared as a solitary destructive skull lesion.

This highlights an important principle in diagnostic radiology:

Rare imaging findings often reveal systemic disease before laboratory abnormalities emerge.

The role of CT scan diagnosis and MRI interpretation becomes essential in these situations.

Understanding Plasmacytoma

What Is a Plasmacytoma?

A plasmacytoma is a neoplasm composed of monoclonal plasma cells. Plasma cells are differentiated B lymphocytes responsible for antibody production.

When plasma cells become malignant, they may proliferate in:

Bone marrow
Bone
Soft tissues
Dura mater
Extramedullary sites

Plasmacytomas are broadly classified into:

Type	Description
Solitary Bone Plasmacytoma	Single osseous lesion
Extramedullary Plasmacytoma	Soft tissue plasma cell tumor
Multiple Myeloma	Multifocal systemic plasma cell malignancy

Dural involvement is rare and often mimics more common extra-axial lesions such as meningioma.

Pathophysiology of Dural-Based Plasmacytoma

Plasma Cell Malignancy and Skull Invasion

The pathophysiology involves clonal proliferation of abnormal plasma cells within marrow-containing bone.

In skull lesions:

Plasma cells infiltrate diploic marrow spaces
Progressive osteolysis develops
Cortical destruction occurs
Soft tissue extension follows
Dural invasion may occur

The resulting lesion frequently demonstrates:

Expansile bone destruction
Hypervascularity
Soft tissue mass formation
Intracranial compression

Unlike meningioma, plasmacytoma primarily destroys bone rather than inducing hyperostosis.

This distinction is crucial in radiology interpretation.

Epidemiology

How Rare Is Dural Plasmacytoma?

Plasmacytoma accounts for a small fraction of plasma cell neoplasms.

Key epidemiologic features include:

Median age: 55–65 years
Male predominance
Skull involvement uncommon
Dural-based lesions extremely rare

Solitary plasmacytoma represents approximately 5% of plasma cell disorders.

Among cranial lesions:

Vertebrae are more commonly affected
Skull base involvement is uncommon
Frontal bone lesions are particularly rare

The rarity contributes to frequent misdiagnosis on initial imaging.

Clinical Presentation

Common Symptoms

Symptoms vary depending on lesion size and location.

Typical manifestations include:

Painless scalp mass
Headache
Local tenderness
Cranial neuropathy
Seizures
Focal neurologic deficits

Interestingly, this patient lacked neurologic symptoms despite partial compression of the brain.

That clinical-radiologic discrepancy is important.

Large lesions may remain deceptively silent.

CT Imaging Findings: The Key to Early Diagnosis

Why CT Matters

Computed tomography remains one of the most important tools in emergency diagnosis and skull lesion characterization.

Figure 1. Axial Non-Contrast CT

The CT scan demonstrated:

A destructive right frontal calvarial lesion
Well-circumscribed soft tissue mass
Peripheral bony fragments
Expansile osteolysis
Intracranial extension
Mild mass effect without midline shift

Radiologic Interpretation

The sharply marginated osteolytic destruction strongly suggests an aggressive neoplastic process.

Key diagnostic clues include:

Absence of calcified matrix
Bone destruction rather than hyperostosis
Extra-axial soft tissue extension
Relatively homogeneous soft tissue density

These findings are highly suspicious of plasmacytoma.

Diagnostic Contribution

The CT findings immediately narrowed the differential diagnosis toward:

Plasmacytoma
Metastasis
Aggressive meningioma
Lymphoma

The lesion measured approximately:

5 cm × 4 cm

Despite its size, there was no midline shift.

This emphasizes the slow-growing nature of many plasma cell tumors.

MRI Features of Dural-Based Plasmacytoma

MRI Characteristics

MRI provides superior soft tissue characterization and evaluation of intracranial extension.

Figure 2. Axial T1 MRI

The lesion demonstrates:

Isointense-to-hypointense signal on T1-weighted imaging
Dural-based extra-axial appearance
Broad dural contact
Compression of the adjacent frontal lobes

Figure 3. Axial MRI

Additional MRI sequences show:

Homogeneous enhancement
Soft tissue extension
Marrow replacement
Adjacent dural thickening

Radiologic Importance

MRI helps determine:

Dural involvement
Brain invasion
Venous sinus compression
Surgical planning
Extent of marrow disease

MRI also differentiates plasmacytoma from chronic hematoma or benign scalp lesions.

Differential Diagnosis

What Else Could This Be?

The imaging differential diagnosis is broad.

Disease	Imaging Features
Meningioma	Hyperostosis, dural tail
Metastasis	Multiple lesions, irregular destruction
Lymphoma	Dense cellular enhancement
Osteitis Fibrosa Cystica	Metabolic bone disease
Paget Disease	Mixed lytic/sclerotic expansion
Hemangioma	Honeycomb appearance
Thalassemia	Marrow expansion without a focal mass

Why Meningioma Is Commonly Misdiagnosed

Dural-based plasmacytoma often resembles meningioma because both are:

Extra-axial
Enhancing
Dural-based

However, plasmacytoma more commonly demonstrates:

Aggressive lytic destruction
Soft tissue expansion
Marrow infiltration

Meanwhile, meningioma usually causes:

Hyperostosis
Calcification
Broad dural tail

Radiology interpretation must focus carefully on bone windows.

Diagnostic Workflow

Step-by-Step Diagnosis Strategy

1. CT Scan Diagnosis

Initial identification of:

Osteolytic skull lesion
Soft tissue extension
Intracranial compression

2. MRI Evaluation

Assessment of:

Dural involvement
Brain compression
Marrow replacement

3. Surgical Resection or Biopsy

Histopathology typically shows:

Monoclonal plasma cells
CD138 positivity
Light-chain restriction

4. Hematologic Evaluation

Essential systemic workup includes:

Serum protein electrophoresis
Urine Bence Jones protein
Bone marrow biopsy
Skeletal survey
PET-CT

5. Diagnosis of Multiple Myeloma

Many patients ultimately meet criteria for systemic disease.

Histopathology Findings

What Pathologists See

Microscopy reveals:

Sheets of plasma cells
Eccentric nuclei
Clock-face chromatin
Abundant basophilic cytoplasm

Immunohistochemistry often demonstrates:

CD138 positivity
Monoclonal kappa or lambda restriction
CD38 positivity

These findings confirm plasma cell neoplasm.

Treatment Strategies

Surgical Management

This patient underwent:

Tumor excision
Cranial mesh reconstruction

Surgery is especially important when lesions cause:

Mass effect
Cosmetic deformity
Neurologic compression

Radiation Therapy

Plasmacytoma is highly radiosensitive.

Radiotherapy provides:

Excellent local control
Reduction of recurrence
Symptom relief

Typical dosing:

40–50 Gy

Systemic Therapy for Multiple Myeloma

When systemic disease is confirmed, treatment may include:

Bortezomib
Lenalidomide
Dexamethasone
Daratumumab
Stem cell transplantation

Modern hematologic therapies have dramatically improved survival.

Prognosis

What Determines Outcome?

Prognosis depends on:

Solitary versus systemic disease
Bone marrow involvement
Cytogenetics
Response to therapy

Solitary plasmacytoma generally has favorable outcomes.

However, progression to multiple myeloma occurs in many patients over time.

Poor prognostic indicators include:

Multiple lytic lesions
High M-protein burden
Renal dysfunction
High-risk cytogenetics

Key Radiology Pearls

Imaging Clues Suggesting Plasmacytoma

Radiologists should suspect plasmacytoma when CT demonstrates:

Solitary destructive skull lesion
Well-defined osteolysis
Soft tissue extension
Dural-based extra-axial mass
Relative lack of calcification

MRI clues include:

Homogeneous enhancement
Marrow replacement
Dural involvement

Emergency Diagnosis Implications

Why Early Recognition Is Critical

Failure to diagnose plasmacytoma early may lead to:

Brain compression
Pathologic fractures
Systemic progression
Renal failure
Spinal cord compression

Emergency radiology interpretation, therefore, plays a major role in patient survival.

Key Takeaways

Dural-based plasmacytoma is a rare presentation of plasma cell malignancy.
CT scan diagnosis is essential for identifying destructive skull lesions.
MRI provides superior evaluation of intracranial and dural involvement.
Bone destruction strongly favors plasmacytoma over meningioma.
Many patients ultimately prove to have multiple myeloma.
Early radiology interpretation dramatically improves outcomes.

Quiz

Question 1

A destructive skull lesion with soft tissue extension and dural involvement is most suggestive of which diagnosis?

A. Meningioma
B. Osteitis fibrosa cystica
C. Paget disease
D. Plasmacytoma
E. Thalassemia

Correct Answer

D. Plasmacytoma

Explanation

Plasmacytoma commonly presents as a sharply circumscribed osteolytic lesion with soft tissue expansion. Bone destruction is more aggressive than typical meningioma.

Question 2

Which imaging feature most strongly favors plasmacytoma over meningioma?

A. Extra-axial location
B. Homogeneous enhancement
C. Dural attachment
D. Hyperostosis
E. Osteolytic bone destruction

Correct Answer

E. Osteolytic bone destruction

Explanation

Plasmacytoma characteristically destroys bone, whereas meningioma more often induces hyperostosis.

Question 3

Which modality best evaluates the intracranial extension of a dural-based skull lesion?

A. Ultrasound
B. Plain radiography
C. MRI
D. Fluoroscopy
E. Nuclear scintigraphy

Correct Answer

C. MRI

Explanation

MRI provides optimal evaluation of dural involvement, brain compression, marrow infiltration, and intracranial extension.

FAQ Section

Can plasmacytoma mimic meningioma?

Yes. Dural-based plasmacytoma frequently resembles meningioma on MRI because both are extra-axial enhancing masses. Bone destruction on CT is the key differentiating feature.

Is plasmacytoma always associated with multiple myeloma?

No. Solitary plasmacytoma can occur independently. However, many patients later develop systemic multiple myeloma.

What is the best imaging modality for skull plasmacytoma?

CT is excellent for identifying osteolytic bone destruction, while MRI is superior for assessing intracranial extension and dural involvement.

Why is early diagnosis important?

Early diagnosis enables timely treatment before progression to systemic disease, neurologic complications, or organ damage.

Conclusion

Dural-based plasmacytoma remains one of the most challenging rare imaging diagnoses in neuroradiology. The lesion may mimic meningioma clinically and radiographically, yet subtle CT findings reveal its true aggressive nature.

This case reinforces a critical lesson in medical imaging:

Careful radiology interpretation of destructive skull lesions can uncover systemic malignancy before laboratory abnormalities appear.

For clinicians involved in MRI, CT scan diagnosis, oncology imaging, emergency diagnosis, and radiology interpretation, awareness of this rare entity is essential for timely diagnosis and life-saving management.